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Abstract
Aims/hypothesis Pro-atherogenic and pro-oxidant, oxidised
LDL trigger adverse effects on pancreatic beta cells,
possibly contributing to diabetes progression. Because
oxidised LDL diminish the expression of genes regulated
by the inducible cAMP early repressor (ICER), we
investigated the involvement of this transcription factor
and of oxidative stress in beta cell failure elicited by
oxidised LDL.
Methods Isolated human and rat islets, and insulin-
secreting cells were cultured with human native or oxidised
LDL or with hydrogen peroxide. The expression of genes
was determined by quantitative real-time PCR and western
blotting. Insulin secretion was monitored by EIA kit. Cell
apoptosis was determined by scoring cells displaying
pycnotic nuclei.
Results Exposure of beta cell lines and islets to oxidised
LDL, but not to native LDL raised the abundance of
ICER. Induction of this repressor by the modified LDL
compromised the expression of important beta cell
genes, including insulin and anti-apoptotic islet brain
1, as well as of genes coding for key components of the
secretory machinery. This led to hampering of insulin
production and secretion, and of cell survival. Silencing
of this transcription factor by RNA interference restored
the expression of its target genes and alleviated beta cell
dysfunction and death triggered by oxidised LDL.
Induction of ICER was stimulated by oxidative stress,
whereas antioxidant treatment with N-acetylcysteine or
HDL prevented the rise of ICER elicited by oxidised LDL
and restored beta cell functions.
Conclusions/interpretation Induction of ICER links oxida-
tive stress to beta cell failure caused by oxidised LDL and
can be effectively abrogated by antioxidant treatment.
Keywords Antioxidant . Apoptosis . Diabetes . HDL .
ICER . Insulin . Oxidative stress . Oxidised LDL .
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Abbreviations
CRE cAMP responsive elements
CREluc Luciferase reporter construct driven by two CRE
sequences linked upstream to a SV40 promoter
hGH Human growth hormone
ICER Inducible cAMP early repressor
JNK c-Jun amino terminal kinase
MAPK Mitogen-activated protein kinase
NAC N-Acetylcysteine
ROS Reactive oxygen species
si Small interfering
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Introduction
A decline in the number of insulin-producing beta cells
and/or their intrinsic ability to produce and/or secrete
insulin contributes to the pathophysiology of type 2
diabetes [1]. Chronic excess of cholesterol and metabolic
fuels, such as the NEFA palmitate and glucose, conspire
with genetic factors to trigger beta cell dysfunction and
destruction over time [2–6]. Low plasma levels of HDL
together with increased levels of oxidised LDL-cholesterol
are associated with diabetes, thereby elevating risk of
developing atherosclerosis and ultimately cardiovascular
diseases [7, 8]. The fact that perturbations of these
lipoproteins precede development of diabetes has led to
the hypothesis that they could contribute to the progres-
sion of the disease [9–12]. So far, numerous clues
support a role for oxidised LDL in triggering adverse
effects in beta cells and thereby contributing to the
pathophysiology of diabetes. Prolonged exposure of
insulin-producing cell lines, as well as isolated human
and rodents islets to oxidised LDL at physiological
cholesterol concentration compromised insulin produc-
tion and secretion, and increased the rates of apoptosis
[6, 13–15], while native LDL at a similar cholesterol
concentration did not exert such adverse effects. Co-
incubation of cells with HDL permitted abrogation of the
harmful effects of oxidised LDL [13]. Positive effects, as
well as protective properties of this particle against
toxicity generated by chronic hyperglycaemia have also
been shown [15, 16], validating the concept that adequate
levels of HDL are required for beta cell function and
control of glucose homeostasis.
A wealth of data point to oxidative stress as the link
coupling oxidised LDL to cell dysfunction and death
[17, 18]. The hypothesis that oxidative stress can
mediate beta cell dysfunction caused by pro-
atherogenic oxidised LDL is further supported by a
clinical trial investigating the efficiency of an antioxi-
dant in cardiovascular events in patients with acute
coronary diseases [19]. Daily administration of the
antioxidant molecule markedly reduced the occurrence
of new-onset diabetes [19]. Furthermore, in vitro induc-
tion of specific signalling cascades supports involvement
of oxidative stress in beta cell failure evoked by oxidised
LDL. Activation of the mitogen-activated protein kinase
(MAPK) pathways, including MAPK8 (also called c-Jun
amino terminal kinase [JNK]), is one of the hallmarks of
oxidative stress [20, 21]. Activation of JNK signalling in
beta cells leads to programmed cell death and impaired
insulin expression [20, 21]. Induction of JNK activity has
been demonstrated to contribute to beta cell dysfunction
caused by oxidised LDL [13].
Increased JNK activity caused by oxidised LDL
results from reduced levels of MAPK8 interacting
protein-1 (also called JNK interacting protein 1 or islet
brain 1), a potent inhibitor of JNK activity in beta cells
[13, 22]. Islet brain 1 is a target of the inducible cAMP
early repressor (ICER), a member of the cAMP
responsive element (CRE) modulator transcription fac-
tors [23]. ICER is a powerful passive repressor, which
silences expression of genes that contain a CRE within
their promoters [24]. Induction of ICER is in part
responsible for beta cell failure evoked by hyperglycaemia
and fatty acids [25, 26]. This negative role is achieved by
silencing expression of insulin [27] and components of the
secretory machinery, such as the GTPases Rab3a and
Rab27a, and their effectors Slp4 (also known as Sytl4) and
Noc2 (also known as Rph3al) [25]. All these observations
led us to investigate whether oxidised LDL may trigger
beta cell failure by inducing production of ICER in a
mechanism that involves oxidative stress.
Methods
Lipoprotein preparation Blood was collected from healthy
donors. Plasma LDL fractions were isolated by sequential
ultracentrifugation (LDL density 1.063) exactly as de-
scribed [13]. Oxidation of LDL particles was done by
incubating 1 mg LDL protein/ml PBS with 5 μmol/l CuSO4
at 37°C for 6–8 h [13]. The oxidation reaction was verified
as previously described by determining the lipid peroxide
content [13].
Cell culture and preparation of isolated islets The insulin-
secreting cell line (MIN6) was maintained as previously
described [13]. Isolated human islets were obtained from
the Cell Isolation and Transplantation Center (islets for
research distribution programme) of the Geneva University
Hospital (Geneva, Switzerland). Investigations were been
approved by the responsible ethics committee. Islets were
cultured in CMRL-1066 supplemented with 10% (vol./vol.)
fetal bovine serum (Mediatech, Herndon, VA, USA) in 5%
CO2 humidified atmosphere at 37°C. Rat islets were
isolated from the pancreas of male Sprague–Dawley rats
weighing 250–350 g by ductal injection of collagenase P
(Roche Diagnostics, Rotkreuz, Switzerland). Purification
and culture of islets was conducted as described [13].
Experimental protocols were approved by the Cantonal
Veterinary Office.
Small interfering RNA and transfection A pool of two 19-
nucleotide pre-validated small interfering (si) RNA duplexes
that target the mouse and rat Icer (also known as Crem)
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sequence (si-Icer) were chemically synthesised by Mycro-
synth (Balgach, Switzerland). The two target sequences of
Icer were: 5′-CTGGAGATGAAACTGCTGC-3′ and 5′-
CTGGAGATGAAACTGATGA-3′. Transient transfection
experiments were performed using a kit (Lipofectamine
2000 transfection; Invitrogen, Basel, Switzerland) as
reported [23].
Measurement of secretion Cells (5×105) were plated in 24-
well dishes and cultured in the presence of vehicle, native
and oxidised LDL for 72 h. When human growth hormone
(hGH) was used as a reporter for regulated secretion, the
cells were first transiently transfected with a construct
encoding the hGH and 24 h later cultured with lipoproteins
for 72 h. Thereafter, the cells were washed three times with
modified KRB HEPES buffer (10 mmol/l HEPES, 0.1%
[wt/vol.] bovine serum albumin) containing insulin secre-
tagogues (20 mmol/l of glucose or 30 mmol/l KCl). Insulin
released in the supernatant fraction and insulin cellular
contents were measured by EIA (Cayman Chemical, Ann
Arbor, MI, USA) as recommended by the manufacturer’s
protocol. Exocytosis from transfected cells was assessed by
ELISA (Roche Diagnostics, Rotkreuz, Switzerland) that
measured the amount of hGH released into the medium
during the incubation period.
Apoptosis assay Apoptosis was determined by scoring cells
displaying pycnotic nuclei (visualised with Hoechst 33342)
[13]. The counting was performed blind by three different
experimenters.
Measurement of superoxide After treatment, MIN6 cells
were washed twice with PBS 1× and scraped in PBS 1×.
Cells were dispersed by pipetting and then 10 μmol/
l lucigenin and 0.2 mmol/l NADPH were added to the cell
suspension. Emitted luminescence was quantified for 12 s
in a luminometer (Berthold, Bad Wildbad, Germany).
Results were normalised to the DNA content measured
using Hoechst 33258 dye (Sigma-Aldrich Chemie, Buchs,
Switzerland).
Western blotting, total RNA preparation and real-time
PCR For western blotting, nuclear extracts were sepa-
rated by SDS-PAGE and blotted on nitrocellulose
membranes as described [13]. The proteins were detected
using specific antibodies and visualised with IRDye 800
(Rockland, Gilbertsville, PA, USA) as secondary anti-
bodies, and quantified in an imaging system (Odyssey
Infrared; Li-COR, Lincoln, NE, USA). Total RNA from
insulin-secreting cell lines and pancreatic islets was
extracted using phenol/chloroform extractions as described
previously [13]. Reverse transcription reactions were per-
formed as previously described [23]. Real-time PCR assays
were carried out on a real-time PCR detection system (MyiQ
Single-Color; Bio-Rad Laboratories, Hercules, CA, USA)
using the iQ SYBR Green Supermix (Bio-Rad Laboratories)
exactly as previously described by Abderrahmani et al. [13].
Primer sequences of rat/mouse origin for Rab3a, Slp4,
Icer and Rplp0 were those published elsewhere [25].
Otherwise primer sequences are described in the electronic
supplementary material [ESM] Table 1.
Statistical analyses Experiments including more than two
groups were analysed by ANOVA or with the non-
parametric equivalent Kruskal–Wallis test.
Results
Oxidised LDL-cholesterol particles hamper insulin produc-
tion and insulin secretion, as well as beta cell survival by
inducing the activity of Icer We first assessed whether
induction of Icer links oxidised LDL to beta cell failure. In
vitro oxidisation of LDL-cholesterol particles by copper
have been previously shown to generate changes in LDL
particles similar to those occurring in endothelial cells,
including lipid peroxidation and extensive hydrolysis of
phosphatidylcholine [28]. To evaluate the effects of
oxidised LDL on beta cells, LDL particles were oxidised
by copper as performed in many reports [6, 29, 30]. Our
previous study had shown that culture of beta cells for
72 h with oxidised LDL containing 2 mmol/l cholesterol
(physiological concentration), diminished the insulin level
and cell survival [13]. Here, reduction in insulin expression
and cell integrity was already visible in cells exposed for
72 h to 1 and 1.5 mmol/l cholesterol of oxidised LDL, but
the effect was less pronounced than with 2 mmol/l choles-
terol of modified LDL (ESM Fig. 1). As previously shown,
0.5 mmol/l oxidised LDL was not efficient in triggering
harmful effects on the cells (ESM Fig. 1) [13]. The decrease
in insulin expression achieved by oxidised LDL occurred at
a time point at which cell death was not yet apparent (ESM
Fig. 2) [13]. This implies that impaired levels of the
hormone are not merely the consequence of a reduced
number of cells caused by apoptosis. While native LDL can
exert deleterious effects on beta cell secretion and prolifer-
ation above 3 mmol/l (A. Abderrahmani and D. Favre,
unpublished observations) [16], the unmodified lipoproteins
at 2 mmol/l cholesterol triggered no effect on beta cell
function [13, 14]. For these reasons, we chose this
cholesterol concentration to carefully investigate the effects
of oxidised LDL. We found a two- to threefold increase in
levels of ICER isoforms in MIN6 and INS-1 cells, as well
as in isolated rat islets cultured with oxidised LDL
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(Fig. 1a). Two ICER isoforms (ICER and ICER Iγ) that
result from alternative splicing of CREM mRNA have been
described [31]. These two isoforms act as transcriptional
repressors whose abundance varies within cell types and
species [31]. MIN6 cells produce one ICER isoform, while
INS-1E cells contain the two forms of the repressor
(Fig. 1b). An increase in the contents of all ICER isoforms
by oxidised LDL was confirmed at the protein level by
western blotting in the two cell types (Fig. 1b). As
anticipated (Fig. 1a, b), neither the protein nor mRNA
levels of the repressor were augmented in response to
native LDL. ICER is a transcriptional passive repressor,
which inhibits the expression of genes that contain a CRE
in their promoter region [24, 32]. This is achieved by
competing with CREB transcriptional activators for binding
to the CRE sequence [24, 32]. To assess the activity of
ICER in response to oxidised LDL, MIN6 cells were
transfected with the luciferase reporter construct driven by
two CRE sequences linked upstream to a SV40 promoter
(CREluc). While native LDL did not modify luciferase
activity, oxidised LDL treatment strikingly decreased
CREluc activity, suggesting that repressor activity of ICER
was elevated (ESM Fig. 3). The expression of target genes
of ICER was next quantified to confirm the increased ICER
activity in response to oxidised LDL. The insulin gene [27],
IB1 (also known as MAPK8IP1) [23] and four genes of the
secretory machinery, the GTPases Rab3a and Rab27a and
their effectors Slp4 and Noc2 [25], are known targets of
ICER. In line with the increase in ICER abundance,
expression of all these target genes was diminished in cells
cultured with oxidised LDL, but not in those cultured with
native particles (Fig. 2a–f). To clearly establish whether
ICER is responsible for these effects, we blocked expres-
sion of the repressor using siRNAs (si-Icer). The efficacy
and specificity of the si-Icer in beta cells has already been
tested in a former study [25]. The mRNA of Ib1 and insulin
in cells cultured with oxidised LDL was partially restored
upon silencing of Icer (Fig. 2a, b). In contrast, silencing of
Icer was able to fully restore the levels of the four genes of
the secretory machinery (Fig. 2c–f).
We next investigated the causal role of ICER in beta
cell dysfunction and death triggered by oxidised LDL.
The decreased expression of Ib1 caused by oxidised LDL
is responsible for sustained induction of the JNK pathway
[13]. Activation of this signalling cascade by oxidised
LDL leads in isolated rat islets and MIN6 cells to
apoptosis through a mechanism involving reduced expres-
sion of B-cell CLL/lymphoma 2 [13]. Consistent with the
restored mRNA Ib1 expression, blockade of ICER
protected the cells against apoptosis evoked by oxidised
LDL (Fig. 3a). As previously reported [14], we found that
oxidised LDL compromise glucose-induced insulin secre-
tion (ESM Fig. 4). Rab3a, Rab27a, Slp4 and Noc2 play
major role in the control of insulin exocytosis [25]. This
led us to assume that the late steps of insulin exocytosis
were impaired in the presence of modified LDL.
Exogenously produced hGH has previously been shown
to be targeted to secretory granules and to be co-
released with insulin after triggering of exocytosis [33].
As, in contrast to insulin, hGH biosynthesis is not affected
by oxidised LDL, secretion of this hormone was used to
directly monitor the exocytotic process in cells cultured
with the lipoproteins. In addition, the use of hGH as a
reporter for exocytosis allows selective assessment of the
secretory process in the fraction of cells that are co-
transfected with the siRNAs. Potassium chloride (KCl) is a
potent insulin secretagogue that triggers exocytosis of
insulin-containing vesicles through direct depolarisation of
the beta cell membrane [34]. Culture of the cells with
oxidised LDL altered secretion elicited by KCl
(Fig. 3b). This result suggests a defect in the distal
steps of the secretory process, which could be the
consequence of reduced expression of Rab3a, Rab27a,
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Fig. 1 mRNA and protein levels of ICER in response to oxidised
LDL. a The mRNA level of Icer was quantified by quantitative real-
time PCR using total RNA from MIN6, INS-1E and isolated rat islet
cells cultured for 72 h with vehicle (white bars), native LDL (hatched
bars) or oxidised LDL (black bars). mRNAwas normalised against the
housekeeping gene, Rplp0, and expression from cells cultured with
vehicle was set to 100%. Data are mean±SEM of three independent
experiments; *p<0.05, **p<0.01 and ***p<0.001. b Quantification
of ICER content in response to oxidised LDL. Total protein from cells
that were cultured with native or oxidised LDL 2 mmol/l cholesterol
was subjected to western blotting analysis. Blot shows results of a
representative experiment (one of three)
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Slp4 and Noc2. Secretion elicited by KCl was completely
restored when expression of Icer was suppressed
(Fig. 3b), confirming the direct role of the repressor in
perturbation of the late steps of insulin secretion caused
by oxidised LDL.
Antioxidant treatment prevents induction of Icer and
oxidised LDL-mediated beta cell failure Oxidised LDL
are potent inducers of oxidative stress in several cell types
[17, 18]. Oxidative stress is a metabolic process that
consists of formation of reactive oxygen species (ROS).
In physiological concentrations, endogenous ROS help to
maintain homeostasis [35]. However, when ROS accumu-
late in excess for prolonged periods as observed for all the
environmental stressors related to diabetes, they trigger
adverse effects [18, 36–39]. Incubation of MIN6 cells with
oxidised LDL elicited a twofold increase in superoxide
production (Fig. 4a). Similar levels were reached in cells
exposed to hydrogen peroxide for 1 h, indicating that
oxidised LDL are potent inducers of oxidative stress in
insulin-secreting cells (Fig. 4a). We then investigated
whether oxidative stress can induce expression of Icer.
Treatment with hydrogen peroxide resulted in four-, two-
and 1.7-fold induction of the expression of Icer, in MIN6
cells, and isolated islets of rat and humans, respectively
(Fig. 4b). To confirm the role of oxidative stress in
induction of Icer achieved by oxidised LDL, the cells
were co-cultured with the modified lipoproteins and the
antioxidant, N-acetylcysteine (NAC) at 1 mmol/l. NAC is
the acetylated precursor of the amino acid L-cysteine and
reduced glutathione. NAC exerts a powerful antioxidant
action by elevating the level of glutathione. Addition of
NAC abolished induction of Icer caused by oxidised LDL
in MIN6, and in isolated islets of rat and humans (Fig. 4c-
e). Co-treatment with NAC enabled partial protection of
the cells against loss of insulin level (Fig. 5a) and
completely restored glucose-induced insulin secretion
executed by oxidised LDL (Fig. 5b). Restoration of the
secretory capacity was in line with the rise in expression
of the genes of the secretory machinery (ESM Fig. 5). Co-
incubation of the cells with NAC prevented cell death
triggered by oxidised LDL in MIN6 and isolated rat islets
(Fig. 5c, d). HDL-cholesterol particles antagonise the
adverse effects of oxidised LDL in beta cells [13, 15]
and display antioxidant properties [40]. Co-culture of
MIN6 cells in the presence of HDL prevented the
induction of Icer caused by oxidised LDL (Fig. 6),
pointing to the repressor as an important link coupling
oxidative stress to beta cell failure achieved by the
modified LDL.
Discussion
Evidence of adverse effects of pro-atherogenic oxidised
LDL on beta cells [13, 15, 16] is now growing. Several
independent in vitro studies agree in pointing to a
deleterious impact of these modified lipoproteins on
insulin level, glucose-induced insulin secretion and ulti-
mately cell survival in different insulin-secreting and islet
cells [13, 15, 16]. Such harmful effects, which are
potentiated by inadequate levels of and/or inactive HDL,
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Fig. 2 Expression of ICER target genes in the presence of oxidised
LDL. mRNA of (a) insulin, (b) Ib1, (c) Rab3a, (d) Rab27a, (e) Noc2
and (f) Slp4 was quantified in MIN6 cells exposed for 72 h to human
native LDL or oxidised LDL containing 2 mmol/l cholesterol. The
cells were transfected with duplexes of control siRNA (si-Gfp)
(white bars) or siRNA directed specifically against ICER (si-Icer,
black bars). mRNA levels were normalised against Rplp0 and
expression from cells cultured with vehicle were set to 100%. Data
are the mean±SEM of three independent experiments; *p<0.05, **p<
0.01 and ***p<0.001
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are thought to promote and contribute to the progression
of diabetes [13, 15]. Our aim here was to understand the
mechanism through which oxidised LDL leads to beta cell
dysfunction. ICER is a basic leucine zipper transcriptional
factor that negatively regulates expression of numerous
genes containing a CRE sequence within their promoter.
The lack of an activation domain makes ICER into a
passive transcriptional repressor [24]. The inhibitory role
of ICER is achieved at certain levels of abundance.
Thereafter, the repressor acts by competing with transcrip-
tional activators and preventing their binding to the CRE
[24]. Induction of ICER is a physiological process that
permits levels of some hormones in endocrine or neuro-
endocrine cells to return to basal [41]. However, persistent
expression of this repressor can occur in response to a
deleterious milieu [41]. In this study, we found that
abnormal induction of ICER links oxidised LDL to beta
cell dysfunction. Selective reduction of ICER contents
partially prevented the loss of insulin expression and cell
death evoked by oxidised LDL. Loss of specialised beta
cell functions caused by the modified lipoproteins preced-
ed cell death. While ICER is responsible for beta cell
failure and death, our observations imply that beta cell
dysfunction driven by the repressor is established prior to
cell death. Variation in islet brain 1 levels is critical for
maintaining appropriate insulin content and cell survival
[13, 22]. As observed in our former study [13], the islet
brain 1 level was dramatically diminished in the face of
oxidised LDL, confirming that loss of islet brain 1
function mediates at least some of the damages to beta
cells provoked by the modified lipoprotein. Reduction of
islet brain 1 abundance inhibits the insulin level and
increases apoptosis by permitting activation of the JNK
pathway [22]. While ICER can directly target the gene
coding for insulin [42], it could also cause the loss of
insulin expression and cell death indirectly by reducing
islet brain 1 content and stimulating the JNK pathway.
However, restoration of levels of the scaffold protein was
incomplete upon silencing of Icer. This coincided with a
partial recovery in insulin production and survival. This
result could not be attributed to efficacy of silencing,
because si-Icer was able to fully restore the mRNA level
of the two other ICER target genes, Noc2 and Rab27a.
These observations suggest that additional factors that are
independent of ICER could have contributed to the
decreased abundance of islet brain 1 provoked by the
modified particle. However, as observed for chronic
hyperglycaemia [25], it is mostly induction of ICER that
operates dysregulation of genes controlling insulin secre-
tion, and thereby the defective secretory capacity of beta
cells caused by oxidised LDL. We found that silencing of
Icer permitted full protection against impairment of
stimulated secretory capacity triggered by oxidised LDL,
a finding that correlates with fully restored expression of
Noc2 and Rab27a.
The major role of ICER in mediating the adverse effects
of oxidised LDL led us to seek the mechanism responsible
for its induction. Many in vitro studies show that oxidised
LDL favour production of ROS and thus oxidative stress in
various cell types [17, 18]. Furthermore, elevated levels of
oxidised LDL correlate with an increase in certain markers
of oxidative stress, such as heat shock protein 70 in patients
with newly diagnosed and long-standing diabetes [43]. For
these reasons, we investigated the role of oxidative stress in
stimulating production of ICER. In this regard, we first
found that oxidised LDL evoked production of superoxide
in beta cells. Second, culture of cells with hydrogen
peroxide elicited an increase in ICER levels. Finally, NAC
antioxidant treatment abrogated the induction of ICER
caused by oxidised LDL. Consistent with this result,
mRNA expression of ICER target genes Rab3a, Rab27a,
Slp4 and Noc2 was restored. This was further accompanied
by full recovery of glucose-induced insulin secretion.
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Fig. 3 Effect of Icer silencing on secretion and survival. aMIN6 cells
were transfected with a control RNA duplex (si-Gfp) (white bars) or
with si-Icer (black bars). Cells were then cultured for 72 h with native
or oxidised LDL 2 mmol/l cholesterol. The fraction of cells
undergoing apoptosis was determined by scoring the percentage of
cells with picnotic nuclei. bMeasurement of insulin exocytosis. MIN6
cells were transiently transfected with hGH together with the control
siRNA (white bars) or si-Icer (black bars), and cultured as above (a).
Secretion of hGH was elicited by pre-incubating cells for 30 min in
KRB containing 2 mmol/l glucose and then incubating them with KCl
30 mmol/l. The amount of hGH released into the medium during the
incubation period and remaining in the cells was measured by ELISA.
The results are expressed as fold increase of stimulated over basal.
Data (a, b) are the mean±SEM of three independent experiments; *p<
0.05 and ***p<0.001
2342 Diabetologia (2011) 54:2337–2346
However, NAC treatment was partially effective in prevent-
ing the loss of insulin transcript accomplished by oxidised
LDL. This observation leads us to assume that another
mechanism, parallel to oxidative stress, accounts for the
partial reduction of insulin caused by the modified LDL.
Administration of NAC strongly improved survival of
MIN6 cells in the presence of oxidised LDL, supporting
the notion of a cytoprotective role of the antioxidant
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l (black bars). The fraction of cells undergoing apoptosis was
determined by scoring cells with pycnotic nuclei. a–d Data are
expressed as the mean±SEM of three independent experiments; *p<
0.05, **p<0.01 and ***p<0.001
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Fig. 4 Role of oxidative stress in the induction of Icer by oxidised
LDL. a Production of superoxide in response to oxidised LDL.
Extracellular ROS were measured by luminescence. MIN6 cells were
cultured for 1 h with oxidised LDL 2 mmol/l (oxLDL) or hydrogen
peroxide 150 μmol/l (H2O2). Superoxide production in cells cultured
with vehicle condition was set to 100%. b Effects of hydrogen
peroxide on the expression of Icer. The mRNA level of Icer was
quantified by quantitative real-time PCR from MIN6 cells, isolated rat
islets cultured for 4 h and human islets cultured for 0.5 h with
hydrogen peroxide 150 μmol/l (black bars). mRNA levels were
normalised against the Rplp0 and expression from cells cultured with
vehicle was set to 100%. c–e Effects of the antioxidant NAC on
expression of Icer evoked by oxidised LDL. The mRNA level of Icer
was quantified by quantitative real-time PCR using total RNA that
was prepared from (c) MIN6 cells, and isolated rat (d) and human (e)
islets cultured for 4 h with oxidised LDL 2 mmol/l cholesterol. The
cells were co-incubated with vehicle (white bars) or NAC (black bars)
1 mmol/l for MIN6 and isolated rat islets (c, d) or 10 mmol/l for
human islets (e). Results were normalised against RPLP0 and
expression from cells cultured with vehicle was set to 100%. a–e
Data are the mean±SEM of three independent experiments; *p<0.05,
**p<0.01 and ***p<0.001
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against the deleterious effects of the modified lipopro-
tein in beta cells. Even though primary beta cells were
not examined, the protective effect of NAC was almost
complete in isolated islets. Activation of the JNK
pathway and decrease of Bcl2 expression are partially
responsible for apoptosis elicited by oxidised LDL [13].
Generation of oxidative stress could therefore be the
leading upstream cause of activation of JNK pathway
and decrease of B-cell CLL/lymphoma 2 levels, in a
mechanism that could also involve ICER.
HDL particles are potent antioxidants [40] and exert
many beneficial effects in beta cells. They not only
stimulate beta cell function [15], but also counter loss
of beta cell functions and cell survival achieved by
oxidised LDL or chronic hyperglycaemia [13, 15, 16]. In
line with this cytoprotective role, we found that HDL
abolished induction of ICER evoked by oxidised LDL. As
observed for oxidised LDL, chronic excess of glucose
elicits beta cell dysfunction and death by generating
intracellular oxidative stress and elevating ICER levels
[25, 44]. Thus, it is very likely that HDL particles
counteract adverse effects provoked by prolonged expo-
sure to glucose by inhibiting oxidative stress and conse-
quently blocking ICER production. However, the plasma
concentration of HDL particles and their activity are
reduced in patients with diabetes or metabolic syndrome
[7, 8]. For this reason, much is being done to find out
effective therapeutic strategies to elevate plasma HDL. It
has, however, been suggested that loss of HDL activity in
patients with type 2 diabetes might be the consequence of
an oxidised LDL-mediated decrease in lecithin-cholesterol
acyltransferase activity [45]. Therefore it is possible that
oxidised LDL elicit oxidative stress and, consequently,
beta cell failure by directly abolishing the protective
effects of HDL. In this case, as long as oxidised LDL are
present, improvement of HDL levels in patients may not
effectively counteract beta cell failure. If this hypothesis is
correct, then the use of other alternative antioxidant
approaches to counteract oxidative stress in beta cells
may be required. Numerous in vitro and in vivo studies
have shown the efficacy of certain antioxidants in
preventing beta cell failure. For example, administration
of the antioxidant NAC alone or in combination with some
vitamins ameliorated glucose-induced insulin secretion in
Zucker diabetic fatty rats and db/db mice [44, 46]. In
contrast, large clinical trials failed to detect an improve-
ment in insulin secretion in patients with type 2 diabetes in
response to antioxidant vitamins [47, 48]. However some
findings in favour of preventive antioxidant therapy to
combat the decline of beta cell function in diabetes have
been reported, in particular, a clinical study originally
devised with the primary endpoint efficacy of the
antioxidant succinobucol in cardiovascular outcomes in
patients with acute coronary disease [19]. Interestingly,
daily administration of the antioxidant succinobuccol has
been found to reduce occurrence of new-onset diabetes by
almost threefold [19]. Succinobuccol is derived from
probucol, a bisphenol molecule that preserves beta cells
by attenuating oxidative stress [49]. NAC is a potent
antioxidant, which is widely used as an antidote for
hepatotoxicity caused by acetaminophen overdose. At
present, a growing body of data supports many other
clinical benefits from use of this antioxidant. These
include: prevention of chronic obstructive pulmonary
disease exacerbation, attenuation of illness from the
influenza virus, treatment of pulmonary fibrosis and
treatment of infertility in patients with clomifene-
resistant polycystic ovary syndrome [50]. Therefore,
antioxidant supplementation in a subset of patients with
low HDL levels and elevated oxidised LDL could help to
prevent beta cell failure and thereby delay the develop-
ment of diabetes.
Induction of ICER by oxidative stress may represent the
unifying mechanism for beta cell failure provoked by
chronic hyperglycaemia, hyperlipidaemia and oxidised
LDL. For the future design of effective and potent
antioxidant preventive treatment, careful examination of
their ability to counteract adverse effects of diabetes
stressors in beta cells will be required.
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to 100%. Data are the mean±SEM of three independent experiments;
*p<0.05 and **p<0.01
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